|
CHEK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.846600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.370400E-04 |
| Normal-vs-Stage2 |
2.515800E-01 |
| Normal-vs-Stage3 |
1.58236999999728E-05 |
| Normal-vs-Stage4 |
3.322900E-03 |
| Stage1-vs-Stage2 |
1.398120E-04 |
| Stage1-vs-Stage3 |
4.785800E-02 |
| Stage1-vs-Stage4 |
3.294800E-01 |
| Stage2-vs-Stage3 |
2.08329999995538E-06 |
| Stage2-vs-Stage4 |
4.449100E-04 |
| Stage3-vs-Stage4 |
6.630400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62528999999578E-05 |
| Normal-vs-AfricanAmerican |
2.238800E-01 |
| Normal-vs-Asian |
4.395700E-03 |
| Caucasian-vs-AfricanAmerican |
3.246600E-01 |
| Caucasian-vs-Asian |
7.528000E-01 |
| AfricanAmerican-vs-Asian |
5.212600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.126060E-02 |
| Normal-vs-Female |
1.988310E-04 |
| Male-vs-Female |
4.190400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.560600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.559200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.081030E-01 |
| Normal-vs-Age(81-100Yrs) |
1.157770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.580800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.062790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.932770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.020800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.308600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.505600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.27950000045263E-07 |
| Classical-VS-Follicular |
1.55431223447522E-14 |
| Classical-VS-Other |
2.950000E-01 |
| Classical-VS-Normal |
1.52229999994535E-06 |
| Tall-VS-Follicular |
<1E-12 |
| Tall-VS-Other |
2.605900E-02 |
| Tall-VS-Normal |
2.18958184916573E-12 |
| Follicular-VS-Other |
1.500630E-01 |
| Follicular-VS-Normal |
1.821870E-02 |
| Other-VS-Normal |
5.018800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.458800E-01 |
| Normal-vs-N1 |
3.67209999996287E-06 |
| N0-vs-N1 |
8.45640000000092E-05 |
|
|
